Part A - Final decisions on matters referred to an expert advisory committee (November 2017)
1. Advisory Committee on Medicines Scheduling (ACMS #22)
1.5 alpha-Pyrrolidinovalerophenone (alpha-PVP) and related substances methylone and synthetic cathinones
On this page: Delegate's final decision | Public submissions on the interim decision |Interim decision | Scheduling proposal
Delegate's final decision
Final decision:
The delegate's final decision is to create new Schedule 9 entries for alpha-pyrrolidinovalerophenone and methylone, and to amend the Schedule 9 entry for cathinone as follows:
Schedule 9 - New Entries
ALPHA-PYRROLIDINOVALEROPHENONE *(ALPHA-PVP).
METHYLONE *(MDMC).
Schedule 9 - Amend Entry
CATHINONES except when separately specified in these Schedules.
Index - New Entries
ALPHA-PYRROLIDINOVALEROPHENONE *(ALPHA-PVP)
Schedule 9
METHYLONE *(MDMC)
Schedule 9
Index - Amend Entry
CATHINONES
cross reference: SYNTHETIC CATHINONES
Schedule 9
Implementation date: 1 June 2018
Reasons:
As no new evidence has been received to alter the interim decision for alpha-pyrrolidinovalerophenone, methylone and cathinones, the delegate has confirmed that the final decision and reasons for the final decision are identical to the interim decision.
Public submissions on the interim decision
No public submissions were received.
Interim decision
The interim decision for alpha-pyrrolidinovalerophenone (alpha-PVP) and related substances methylone and synthetic cathinones was published on the TGA website on 5 February 2018 at Scheduling delegates' interim decisions and invitation for further comment: ACCS/ACMS, November 2017 - 1.5. Alpha-Pyrrolidinovalerophenone (alpha-PVP) and related substances methylone and synthetic cathinones.
Scheduling proposal
The pre-meeting scheduling proposal for alpha-pyrrolidinovalerophenone (alpha-PVP) and related substances methylone and synthetic cathinones was published on the TGA website on 6 September 2017 at Consultation: Proposed amendments to the Poisons Standard - ACCS, ACMS and Joint ACCS/ACMS meetings, November 2017.